A number of spin-out companies have been formed by research scientists from the School of Medicine.
Exonate is a biopharmaceutical company focused on the discovery and development of small molecule drugs. They're specifically interested in those which modulate alternative mRNA splicing to address diseases of high unmet medical need.
Visit Exonate website
FaHRAS is a sophisticated evidence-based software system that enables the user to build and store a family history. It also runs a variety of analyses against their family history to quantify their risk of developing breast cancer.
Visit FaHRAS website
NuVision was incorporated on 10 July 2014 and aims to develop and accelerate to market new regenerative therapies. Initially focused on treating eye disease and trauma, it's now expanding into the chronic wound arena.
Visit NuVision website
Platelet Solutions was formed in 2011 focusing on platelet function testing in any healthcare setting.
Scancell’s mission is to develop products that stimulate the immune system to treat or prevent cancer.
Visit Scancell website